Cardiff University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Cardiff University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011826
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cardiff University is an educational institute that provides educational and research services. The institute offers services such as undergraduate courses, post graduate courses, international courses, accommodations, and libraries, among others. It conducts research in the areas of engineering and physical sciences, bio-medical and life sciences, and arts, humanities, and social sciences. Cardiff University offers courses in various disciplines including accounting, history, language, archaeology, architecture, astrophysics, banking and finance, biology, bio-medical science, biotechnology, business management, chemistry, civil engineering, computer science, criminology, dentistry, ecology, environment, geology, and others. The institute operates in Cardiff and Wales, the UK. Cardiff University is headquartered in Cardiff, the UK.

Cardiff University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Cardiff University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Diamyd Medical Enters into Partnership with Cardiff University 10
Licensing Agreements 11
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University – Key Competitors 14
Cardiff University – Key Employees 15
Cardiff University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Government and Public Interest 18
Nov 17, 2017: Improved method of engineering T-cells to attack cancer 18
Aug 31, 2016: Potential New Treatment for Cocaine Addiction 19
Jul 07, 2016: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 20
Jul 07, 2016: Midatech Pharma: Grant funding received to explore Midatech’s gold nanoparticle technology in immunotherapy 21
May 05, 2016: Drug combination could help reduce risk of death in type 2 diabetes 22
Jan 13, 2016: Upgrading the immune system : Cardiff University 23
Jan 06, 2016: In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Cardiff University, Pharmaceuticals & Healthcare, Key Facts 2
Cardiff University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Cardiff University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Cardiff University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Cardiff University, Deals By Therapy Area, 2011 to YTD 2017 8
Cardiff University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Diamyd Medical Enters into Partnership with Cardiff University 10
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 11
Cancer Research Technology, Cardiff University, And Institute of Cancer Research Extend Licensing Agreement With Merck Serono 12
Cardiff University, Key Competitors 14
Cardiff University, Key Employees 15
Cardiff University, Other Locations 16
Cardiff University, Subsidiaries 17

★海外企業調査レポート[Cardiff University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lingui Developments Berhad (LINGUI):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Lingui Developments Berhad" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictl …
  • Best Western International, Inc.:企業の戦略・SWOT・財務分析
    SummaryBest Western International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Cholamandalam Investment and Finance Company Limited (CHOLAFIN):企業概要、財務及び戦略的SWOT分析
    Summary Cholamandalam Investment and Finance Company Limited (CIFCL) is a financial service provider. The company offers vehicle finance, home loans, home equity loans, SME loans, investment advisory services, stock broking and other financial services to its customers. Its products include commerci …
  • Eagle Cement Corporation (EAGLE):企業の財務・戦略的SWOT分析
    Eagle Cement Corporation (EAGLE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mega Uranium Ltd. (MGA):企業の財務及び戦略的SWOT分析
    Mega Uranium Ltd. (MGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Micronet Ltd. (MCRNL):企業財務及び戦略的SWOT分析
    Summary Micronet Ltd. (Micronet) is a technology company that develops, manufactures and markets mobile computing platforms. The company provides products such as mobile data terminals and development tool kit. It offers advanced MDTs, mid-range MDTs, entry-level MDTs, Android based MDT, color and t …
  • OJSC Magnit:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' OJSC Magnit Mergers and Acquisi …
  • NKT Therapeutics, Inc.(製薬・医療分野):企業M&A動向
    Summary NKT Therapeutics, Inc. (NKT) is a biotechnology company. The company develops therapeutics based on immune cells called natural killer T cells. It develops products for the treatment of sickle cell anemia, autoimmune diseases and inflammatory diseases, cancer, asthma and dermatitis. NKT deve …
  • Ono Pharmaceutical Co Ltd (4528):企業のM&A・提携動向(医療機器分野)
    Summary Ono Pharmaceutical Co Ltd(Ono Pharmaceutical) is a research-based pharmaceutical company, which carries out the discovery, production and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes Rivastach, Glactiv, Forxiga, Emend, Staybla, Recalbon, Opalmo …
  • United Orthopedic Corporation (4129):企業の財務及び戦略的SWOT分析
    Summary United Orthopedic Corporation (UOC) is a medical device company that designs, manufactures and distributes orthopedic implants and instrument sets. The company’s product categories include hip replacement systems, knee replacement systems, and oncology products. It offers hip replacement sys …
  • Heptares Therapeutics, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Heptares Therapeutics, Ltd. Mer …
  • Sorgenia SpA(エネルギー分野):企業M&A動向
    Summary Sorgenia SpA (Sorgenia) is an electricity generator and energy utilities company. The group operates in the energy and natural gas sector. Sorgenia produces, imports, and sells electricity and gas. The group also offers various integrated power saving equipments and services. Sorgenia is a g …
  • Solo Oil plc (SOLO)(石油・ガス分野):企業M&A動向
    Summary Solo Oil plc (Solo Oil), formerly Immersion Technologies International Plc, is an oil and gas company. It acquires and develops a diverse portfolio of oil & gas assets in Europe, the Americas and Africa. The company acquires both on-shore and off-shore interests. The company’s non-operated o …
  • Exploit Technologies Pte Ltd:(医療機器分野)企業M&A及び提携動向
    Summary Exploit Technologies Pte Ltd (Exploit Technologies) is a technology transfer company. It provides technologies for license in various sectors industries such as Electronics, energy, Environment, food, life sciences, medical devices, diagnostics, pharmaceuticals and others. The company offers …
  • Luitpold Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Luitpold Pharmaceuticals Inc (Luitpold), a subsidiary of Daiichi Sankyo Company Ltd is a manufacturer and marketer of drugs and medical devices. The company provides injectable parenteral medications that are used in pharmacy admixtures and nutrient solutions, antidotes, critical care drugs, …
  • Strat Aero Plc (AERO):企業財務及び戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) is an aerospace company that provides training solutions, consultancy services and management systems to the Unmanned Aerial Vehicle (UAV) sector. The company offer wide range of services such as intelligence, surveillance and reconnaissance services, survey and i …
  • BioExx Specialty Proteins, Ltd. (Formerly, Bio-Extraction, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BioExx Specialty Proteins, Ltd. …
  • Parallel Energy Trust (PLT.UN)(石油・ガス分野):企業M&A動向
    Summary Parallel Energy Trust (Parallel Energy) is an unincorporated open-ended limited purpose energy trust. It provides stable and consistent returns for investors by increasing its assets and operations. The trust focuses on the acquisition and development of conventional oil and natural gas asse …
  • McKesson Corporationの企業概要及び財務/SWOT分析
    McKesson Corporation Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, McKesson Corporation annual and quarterly forecasts made by stock market experts. The report also enables …
  • Ritek Corporation (2349):企業概要、財務及び戦略的SWOT分析
    Summary Ritek Corporation (Ritek) is an optical storage media product manufacturer. The company offers products such as flash memory products, recordable media, portable hard drive, pre-recorded media, power bank, flat panel display, DRAM modules, and LED products. It also produces HD DVD media for …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆